20 Matching Annotations
  1. Aug 2025
  2. journals.sagepub.com journals.sagepub.com
    NAT2: A Novel Target in Intrahepatic Cholangiocarcinoma and its Role in Modulating Tumor Behavior
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    journals.sagepub.com/doi/full/10.1177/11795549251360481
  3. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    NAT2: A Novel Target in Intrahepatic Cholangiocarcinoma and its Role in Modulating Tumor Behavior
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12358714/
  4. Jun 2025
  5. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/5788f38b4bbfefdb72cde14acc900869637691f1/PDF-html.html
  6. Apr 2025
  7. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Idarubicin-transarterial chemoembolization combined with gemcitabine plus cisplatin for unresectable intrahepatic cholangiocarcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11995345/
  8. Jan 2025
  9. www.nature.com www.nature.com
    Re-evaluation of the relationship between PrPc expression and patient prognosis in primary esophageal squamous cell carcinoma and primary hepatocellular carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41598-024-82398-4
  10. Nov 2024
  11. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    YAP‐TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11532981/
  12. Oct 2024
  13. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    NAPRT silencing in FH-deficient renal cell carcinoma confers therapeutic vulnerabilities via NAD+ depletion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11445649/
  14. May 2024
  15. 52.53.155.43 52.53.155.43
    Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/3f07be0ebaa016d2b81ff2554651fc11f237f3a0/pharmaceuticals-17-00197-html.html
  16. Apr 2024
  17. www.sciencedirect.com www.sciencedirect.com
    Modulating PCGF4 stability is an efficient metastasis-regulatory strategy utilized by distinct subtypes of Cancer-Associated Fibroblasts in intrahepatic cholangiocarcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0002944024001603
  18. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10997361/
  19. Feb 2024
  20. www.sciencedirect.com www.sciencedirect.com
    S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0304383524001022
  21. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Exploring the apoptotic effects of sericin on HCT116 cells through comprehensive nanostring transcriptomics and proteomics analysis
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10825148/
  22. Jan 2024
  23. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10330233/
  24. Jul 2023
  25. 52.53.155.43 52.53.155.43
    ccr-23-0036-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/a37b63e26bcfde1a55ec087b50c7e67814b42741/ccr-23-0036-html.html
  26. Oct 2022
  27. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    COMPREHENSIVE DRUG RESPONSE PROFILING AND PAN-OMIC ANALYSIS IDENTIFIED THERAPEUTIC CANDIDATES AND PROGNOSTIC BIOMARKERS FOR ASIAN CHOLANGIOCARCINOMA
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9563539/
  28. Aug 2022
  29. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9350976/
  30. Jun 2022
  31. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Polymethoxylated flavone sudachitin is a safe anticancer adjuvant that targets glycolysis in cancer‑associated fibroblasts
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9185147/
  32. Jan 2022
  33. onlinelibrary.wiley.com onlinelibrary.wiley.com
    Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/ijc.33930
  34. Dec 2021
  35. www.sciencedirect.com www.sciencedirect.com
    Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610821006590
  36. Oct 2021
  37. www.sciencedirect.com www.sciencedirect.com
    STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004221011913